Temporally, her presentation was associated with the initiation of HER2-directed therapy; alternative etiologies such as anemia, hepatic or renal dysfunction, bullous pemphigoid, or drug hypersensitivity reactions were effectively excluded through laboratory and clinical assessment. The gene discussed is ERBB2; the disease is bullous pemphigoid.